IT | EN

Clinical Ocular Dysbiosis

Symptoms, signs, and emerging scientific evidence.

Information Note on Clinical Correlations

The described correlations between dysbiosis and ocular symptoms are subject to ongoing scientific research. Microbiota diagnostics represents a second-level integrative tool, and rebalancing strategies do not replace primary ophthalmological therapies. Every evaluation must be contextualized by the specialist.

Clinical ocular dysbiosis generally does not manifest as a single isolated pathology but as a transversal condition that can interfere with and aggravate various inflammatory diseases of the ocular surface.

Certain Evidence (Strong)
Reported Symptoms
Burning, foreign body sensation, persistent itching.
Clinical Signs
Tear film instability (reduced TBUT), conjunctival hyperemia.
Probable Evidence (Growing)
Reported Symptoms
Sensation of chronic eye pain, photophobia, fluctuating vision.
Clinical Signs
Meibomian gland dysfunction (MGD), altered secretions.
Possible Evidence (Emerging)
Reported Symptoms
Nocturnal eye heaviness, intense dryness upon awakening.
Clinical Signs
Reduced goblet cells, altered corneal sensitivity.

🧠 Neurosensory Inflammation

Recent studies suggest dysbiosis may influence ocular pain thresholds, possibly by reducing the action of protective neuropeptides in tears.

🦠 The Role of Biofilms

In chronic blepharitis, microbial biofilms create protective matrices hosting pathogens, potentially limiting the effectiveness of standard eyelid hygiene alone.

Potential Clinical Utility of the Test

🎯 Therapy Support

Providing data to evaluate rebalancing strategies and limit the empirical use of broad-spectrum antibiotics.

🛡️ Stewardship

Detecting potential bacterial resistance genes before complex ocular surgical interventions.

🔍 Refractory Cases

Offering additional biological elements ("microbial signature") to frame persistent symptoms without apparent cause.

🌐 Systemic Value

Supporting the study of the correlation between local imbalance and potential systemic (e.g., gut) dysbiosis.

🔬 ACCESS SCIENTIFIC INSIGHTS 💬 EYE DOCTOR Q&A (READ FAQs)
References: TFOS DEWS II (2017); Wang Y. et al. (2025); Watters G. A. et al. (2023).